Kai Rossen
About Kai Rossen
Kai Rossen serves as the Editor In Chief at the American Chemical Society and is the Chief Scientific Officer at Euroapi. He has extensive experience in the pharmaceutical industry, having held leadership roles at companies such as sanofi-aventis, Lundbeck, and Merck.
Current Role at American Chemical Society
Kai Rossen serves as the Editor In Chief at the American Chemical Society. He has held this position since 2015, contributing to the organization for nine years. In this role, he oversees editorial processes and ensures the quality of published research within the field of chemistry.
Current Position at Euroapi
Since 2020, Kai Rossen has been the Chief Scientific Officer at Euroapi. He operates from Frankfurt am Main, Hesse, Germany, and has been with the company for four years. In this capacity, he leads scientific initiatives and strategic direction for the organization.
Previous Experience at Sanofi-Aventis
Kai Rossen worked at Sanofi-Aventis as Group Leader in Research from 2005 to 2017, accumulating twelve years of experience in the Frankfurt Am Main Area, Germany. His role involved leading research teams and projects within the pharmaceutical sector.
Leadership Role at Lundbeck
From 2017 to 2020, Kai Rossen held the position of Vice President of Development at Lundbeck. During this three-year tenure, he was responsible for overseeing development processes and strategies in the pharmaceutical industry, based in the Frankfurt Am Main Area, Germany.
Educational Background at Cornell University
Kai Rossen studied Chemistry at Cornell University, where he earned his Ph.D. from 1983 to 1987. This educational foundation provided him with extensive knowledge and expertise in the field of chemistry, supporting his subsequent professional endeavors.